Assessment of celecoxib pharmacodynamics in pancreatic cancer.
Jimeno A, Amador ML, Kulesza P, Wang X, Rubio-Viqueira B, Zhang X, Chan A, Wheelhouse J, Kuramochi H, Tanaka K, Danenberg K, Messersmith WA, Almuete V, Hruban RH, Maitra A, Yeo CJ, Hidalgo M.
Jimeno A, et al. Among authors: yeo cj.
Mol Cancer Ther. 2006 Dec;5(12):3240-7. doi: 10.1158/1535-7163.MCT-06-0565.
Mol Cancer Ther. 2006.
PMID: 17172427
Clinical Trial.